Literature DB >> 22095283

Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

J A Trapani1.   

Abstract

Within the powerful legacy left by Jurg Tschopp, we should not forget his early work that helped to elucidate the molecular pathways responsible for the clearance of virus-infected and transformed cells by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Jurg's skilful biochemical approach formed a firm platform upon which the work of so many other biochemists, cell biologists and immunologists would come to rely. Jurg coined the shorthand term 'granzyme' to denote the individual members of a family of serine proteases sequestered in and secreted from the cytotoxic granules of CTL/NK cells. He was also one of the first to describe the lytic properties of purified perforin and to postulate the synergy of perforin and granzymes, which we now know to underpin target cell apoptosis. Jurg was a major protagonist in the debate that raged throughout the 1980's and early 1990's on the physiological relevance of the 'granule exocytosis' pathway. Ultimately, resolving this issue led Jurg and his colleagues to even greater and impactful discoveries in the broader field of apoptosis research. Jurg Tschopp ranks with other pioneers, particularly Gideon Berke, Chris Bleackley, Pierre Golstein, Pierre Henkart and Eckhard Podack for making seminal discoveries on our understanding of how the immune system eliminates dangerous cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095283      PMCID: PMC3252834          DOI: 10.1038/cdd.2011.156

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  65 in total

Review 1.  Debate: the mechanism of lymphocyte-mediated killing. Perforin-induced pore formation.

Authors:  O Krähenbühl; J Tschopp
Journal:  Immunol Today       Date:  1991-11

2.  Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes.

Authors:  H Kojima; N Shinohara; S Hanaoka; Y Someya-Shirota; Y Takagaki; H Ohno; T Saito; T Katayama; H Yagita; K Okumura
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

3.  Absence of homologous restriction factor does not affect CTL-mediated cytolysis.

Authors:  O P Krähenbühl; H H Peter; J Tschopp
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

4.  Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin.

Authors:  J Tschopp; S Schäfer; D Masson; M C Peitsch; C Heusser
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

5.  Lack of DNA degradation in target cells lysed by granules derived from cytolytic T lymphocytes.

Authors:  S H Gromkowski; T C Brown; D Masson; J Tschopp
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.

Authors:  G Berke; D Rosen
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

7.  Granzyme B.

Authors:  M C Peitsch; J Tschopp
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

8.  Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A.

Authors:  J W Shiver; L Su; P A Henkart
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

Review 9.  Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.

Authors:  D E Jenne; J Tschopp
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

Review 10.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

View more
  8 in total

1.  IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

Authors:  J Silke; J E Vince
Journal:  Cell Death Differ       Date:  2012-01       Impact factor: 15.828

2.  Detection of Cancer Cell Death Mediated by a Synthetic Granzyme B-like Peptide Fluorescent Conjugate and the same Peptide Binding in Bacteria.

Authors:  Wai Chun Jennifer Lo; Donald Gene Luther
Journal:  J Fluoresc       Date:  2013-10-24       Impact factor: 2.217

3.  Efferocytosis is an innate antibacterial mechanism.

Authors:  Constance J Martin; Matthew G Booty; Tracy R Rosebrock; Cláudio Nunes-Alves; Danielle M Desjardins; Iris Keren; Sarah M Fortune; Heinz G Remold; Samuel M Behar
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

4.  ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.

Authors:  Anatoli M Malyguine; Susan Strobl; Kimberly Dunham; Michael R Shurin; Thomas J Sayers
Journal:  Cells       Date:  2012-05-10       Impact factor: 6.600

5.  The role of death-associated protein 3 in apoptosis, anoikis and human cancer.

Authors:  Umar Wazir; Mona Maw Orakzai; Zubair S Khanzada; Wen G Jiang; Anup K Sharma; Abdul Kasem; Kefah Mokbel
Journal:  Cancer Cell Int       Date:  2015-04-10       Impact factor: 5.722

Review 6.  Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity?

Authors:  Esen Yonca Bassoy; Michael Walch; Denis Martinvalet
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

7.  Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma.

Authors:  Yuxue Gao; Qingguo Xu; Xinqiang Li; Yuan Guo; Bowen Zhang; Yan Jin; Cunle Zhu; Yuntai Shen; Pengxiang Yang; Ying Shi; Rifeng Jin; Daojie Liu; Yabo Ouyang; Xiaoni Liu; Wenjing Wang; Dexi Chen; Tongwang Yang
Journal:  Cell Death Dis       Date:  2022-03-07       Impact factor: 9.685

Review 8.  Potential role of extracellular granzyme B in wet age-related macular degeneration and fuchs endothelial corneal dystrophy.

Authors:  Eden Dubchak; Gideon Obasanmi; Matthew R Zeglinski; David J Granville; Sonia N Yeung; Joanne A Matsubara
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.